Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
about
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trialRadiofrequency ablation in the treatment of liver metastases from colorectal cancerShort and long-term outcomes of laparoscopic compared to open liver resection for colorectal liver metastasesMissing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastasesPharmacologic resistance in colorectal cancer: a reviewColorectal cancer: Metastases to a single organRecurrence after hepatic resection in colorectal cancer liver metastasis -Review article-Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumorsPrimary metastatic breast cancer: the impact of locoregional therapyDesigning liver resections and pushing the envelope with resections for hepatic colorectal metastasesEvolving ablative therapies for hepatic malignancyMulti-modality treatment of colorectal liver metastasesLaparoscopic-assisted ablation of hepatic tumors: a reviewRole of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a reviewRadiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysisLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Visualisation of liver tumours using hand-held real-time strain imaging: results of animal experiments.The ongoing history of thermal therapy for cancerMRI-compatible manipulator with remote-center-of-motion control.Near-infrared fluorescence-guided resection of colorectal liver metastases'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma.Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancerInteraction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatmentThe Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series.Multidisciplinary approach of colorectal cancer liver metastases.Management of stage IV rectal cancer: palliative options.Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastasesWhat defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.Two-stage strategy for patients with extensive bilateral colorectal liver metastases.Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases.Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases.Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomesAblative therapies for colorectal liver metastases: a systematic review.Treatment planning and image guidance for radiofrequency ablation of large tumors
P2860
Q21260391-CF983593-670A-453A-806F-94E78CF42CABQ24202637-85DF4D1A-C61B-4044-BC44-86FAB51B8E01Q26738540-B342C26E-2A88-45C3-BDC8-D47D8AD4423EQ26751389-635AAF1C-3017-43CA-ABD4-25EF1AA928DCQ26769850-538B4AA2-43D3-4EB1-81D9-089382CC159DQ26778009-AF723FA4-90EB-4691-B479-B5794D812038Q26781491-3D1F76C9-533C-4156-B380-E994B6B7F266Q26822537-BB131FC7-8940-489B-9A34-F48EE5C52E8AQ26851149-4E813C38-30FA-4806-9ED8-F520F5BBAF72Q26864128-E86564B6-000E-4BF7-AD7B-83638707BA7EQ27002551-EB5D062B-5DA0-40E8-B497-424E0D6B9005Q27006832-9804670B-3025-4C6D-BBE3-64EB4C2DBC36Q27021321-766E90AD-34BF-4F08-90CE-B6E289593A67Q28083048-22DFA7FF-6E03-4150-B760-BFF0B713EF96Q30240094-18C02929-7BAC-4A3C-9EFA-BEFA35748B8BQ30415022-12288430-71AA-476A-8722-776B36993F16Q30449862-D7587CDA-7EBC-419E-96C6-713D751C6E8DQ30469171-398AAF23-B557-4FF0-9DC8-7F5F997CE586Q30492976-BB7B59EE-F5F6-4F7E-93E8-5ECF09468A49Q30544936-2112AFA1-3E39-4D6C-A4DF-348BE8AFFCA3Q33515915-0D55B2D7-9826-4E98-B1AB-FF1C051D8313Q33560473-43D93967-6AA1-450F-8DEA-3D42B20FCADCQ33563648-63CB37CD-DCC9-4DD7-AD24-2E430BB9A0F4Q33582556-E5DE5F78-E452-4CF1-8DC9-9875B719348EQ33679628-117A2A18-47AB-429B-872E-3D255CB3D2BBQ33690475-7677E2DF-8508-4B3E-97E9-A0D10F5A282AQ33715042-020938B0-64CF-47D4-B503-17334E8B5F8DQ33776697-0EB198C6-0A3F-4348-BAE1-8A9C7D287BCBQ33777340-02A28E2A-74CB-40A5-8CD6-EAD27839EC6EQ33779859-E29A653E-753A-4E58-9A8D-FC639F1643F7Q33849034-716F808E-9A25-466F-9A9D-9172C7CA0822Q33850209-314AD6DD-4D6F-4520-83E0-DE66B845A01EQ33865014-CCFC38FE-92C0-4BB1-9176-B3C1F755E0C2Q33865026-8C74B74C-63E3-4DB8-99CA-FB4F685B1502Q33873948-FC6B4846-DD2D-4271-905D-1CCD2852CA6CQ33909734-CA4D09E9-3A7A-4F6F-A2EE-4A41F463E6A9Q33914458-78255103-B5DD-489B-BBF6-CCBBFF14A2BDQ33935631-5E68D95D-0A30-4650-81EE-8A1A2CA69429Q33937325-058EC347-2136-4192-A110-855E97E5673FQ33959985-04E9E89A-3DD6-4E59-A7C5-FB55112C16B1
P2860
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Recurrence and outcomes follow ...... r colorectal liver metastases.
@en
Recurrence and outcomes follow ...... r colorectal liver metastases.
@nl
type
label
Recurrence and outcomes follow ...... r colorectal liver metastases.
@en
Recurrence and outcomes follow ...... r colorectal liver metastases.
@nl
prefLabel
Recurrence and outcomes follow ...... r colorectal liver metastases.
@en
Recurrence and outcomes follow ...... r colorectal liver metastases.
@nl
P2093
P2860
P1433
P1476
Recurrence and outcomes follow ...... r colorectal liver metastases.
@en
P2093
Eddie K Abdalla
Jean-Nicolas Vauthey
Kenneth Hess
Kristine R Broglio
Lee M Ellis
Raphael Pollock
Steven A Curley
Vickie Ellis
P2860
P304
818-25; discussion 825-7
P356
10.1097/01.SLA.0000128305.90650.71
P407
P577
2004-06-01T00:00:00Z